AGIO

Agios Pharmaceuticals, Inc. Press Releases

$114.43
*  
4.76
4.34%
Get AGIO Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading AGIO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Agios Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
12/16/2014 4:05:00 PM - GlobeNewswire


Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock
12/10/2014 8:41:00 PM - GlobeNewswire


Agios Pharmaceuticals Announces Proposed Offering of Common Stock
12/9/2014 4:22:00 PM - GlobeNewswire


Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors
12/9/2014 4:01:00 PM - GlobeNewswire


Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency
12/8/2014 1:00:00 PM - GlobeNewswire


Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016
12/8/2014 7:30:00 AM - GlobeNewswire


Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies
12/7/2014 12:30:00 PM - GlobeNewswire


Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)
11/18/2014 6:01:00 PM - GlobeNewswire


Flagship VentureLabs™ Introduces Symbiota, Pioneer of Agricultural Innovation Through the Plant Microbiome
11/13/2014 8:30:00 AM - PR Newswire


Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
11/7/2014 7:00:00 AM - GlobeNewswire


Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting
11/6/2014 9:07:00 AM - GlobeNewswire


Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014
10/27/2014 8:30:00 AM - GlobeNewswire


Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation
10/21/2014 8:30:00 AM - GlobeNewswire


Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221
10/15/2014 7:30:00 AM - GlobeNewswire


Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014
10/6/2014 9:00:00 AM - GlobeNewswire